News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
177,488 Results
Type
Article (17176)
Company Profile (18)
Press Release (160294)
Multimedia
Podcasts (17)
Webinars (9)
Section
Business (51951)
Career Advice (378)
Deals (8628)
Drug Delivery (48)
Drug Development (30648)
Employer Resources (38)
FDA (4765)
Job Trends (4567)
News (93975)
Policy (8437)
Tag
Academia (1029)
Accelerated approval (3)
Adcomms (13)
Allergies (36)
Alliances (12657)
ALS (45)
Alzheimer's disease (997)
Antibody-drug conjugate (ADC) (77)
Approvals (4724)
Artificial intelligence (107)
Autoimmune disease (13)
Automation (5)
Bankruptcy (61)
Best Places to Work (3706)
BIOSECURE Act (8)
Biosimilars (40)
Biotechnology (10)
Bladder cancer (52)
Brain cancer (17)
Breast cancer (211)
Cancer (1426)
Cardiovascular disease (94)
Career advice (325)
Career pathing (18)
CAR-T (92)
CDC (11)
Cell therapy (210)
Cervical cancer (16)
Clinical research (25151)
Collaboration (350)
Company closure (2)
Compensation (50)
Complete response letters (5)
COVID-19 (1373)
CRISPR (26)
C-suite (129)
Cystic fibrosis (39)
Data (1301)
Decentralized trials (1)
Denatured (2)
Depression (30)
Diabetes (125)
Diagnostics (2946)
Digital health (8)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (53)
Drug pricing (57)
Drug shortages (15)
Duchenne muscular dystrophy (53)
Earnings (21045)
Editorial (30)
Employer branding (5)
Employer resources (39)
Events (20565)
Executive appointments (368)
FDA (5363)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (351)
Gene editing (68)
Generative AI (10)
Gene therapy (179)
GLP-1 (374)
Government (1531)
Grass and pollen (1)
Guidances (81)
Healthcare (5292)
Huntington's disease (16)
IgA nephropathy (19)
Immunology and inflammation (89)
Immuno-oncology (3)
Indications (16)
Infectious disease (1445)
Inflammatory bowel disease (49)
Inflation Reduction Act (3)
Influenza (21)
Intellectual property (44)
Interviews (81)
IPO (4235)
IRA (19)
Job creations (1044)
Job search strategy (257)
Kidney cancer (8)
Labor market (16)
Layoffs (243)
Leadership (10)
Legal (1442)
Liver cancer (33)
Lung cancer (209)
Lymphoma (107)
Machine learning (3)
Management (14)
Manufacturing (132)
MASH (43)
Medical device (3230)
Medtech (3232)
Mergers & acquisitions (4607)
Metabolic disorders (367)
Multiple sclerosis (49)
NASH (12)
Neurodegenerative disease (77)
Neuropsychiatric disorders (19)
Neuroscience (1316)
NextGen: Class of 2025 (1612)
Non-profit (1380)
Now hiring (2)
Obesity (213)
Opinion (133)
Ovarian cancer (43)
Pain (31)
Pancreatic cancer (64)
Parkinson's disease (95)
Partnered (7)
Patents (80)
Patient recruitment (52)
Peanut (19)
People (16053)
Pharmaceutical (4)
Pharmacy benefit managers (9)
Phase I (7936)
Phase II (11249)
Phase III (8888)
Pipeline (790)
Policy (75)
Postmarket research (710)
Preclinical (2654)
Press Release (28)
Prostate cancer (61)
Psychedelics (13)
Radiopharmaceuticals (107)
Rare diseases (202)
Real estate (1410)
Recruiting (13)
Regulatory (6366)
Reports (12)
Research institute (981)
Resumes & cover letters (43)
Rett syndrome (4)
RNA editing (5)
RSV (25)
Schizophrenia (38)
Series A (71)
Series B (41)
Service/supplier (1)
Sickle cell disease (22)
Special edition (7)
Spinal muscular atrophy (86)
Sponsored (12)
Startups (1472)
Stomach cancer (6)
Supply chain (16)
Tariffs (37)
The Weekly (15)
Vaccines (376)
Venture capital (35)
Weight loss (147)
Women's health (12)
Worklife (5)
Date
Today (50)
Last 7 days (213)
Last 30 days (953)
Last 365 days (11334)
2025 (5542)
2024 (11903)
2023 (13197)
2022 (16113)
2021 (16894)
2020 (15866)
2019 (12181)
2018 (9472)
2017 (9517)
2016 (8515)
2015 (9587)
2014 (6452)
2013 (4774)
2012 (5213)
2011 (5505)
2010 (4806)
Location
Africa (214)
Alabama (15)
Alaska (1)
Arizona (41)
Arkansas (3)
Asia (11141)
Australia (2233)
California (2475)
Canada (649)
China (261)
Colorado (85)
Connecticut (82)
Delaware (79)
Europe (27271)
Florida (310)
Georgia (55)
Idaho (7)
Illinois (184)
India (15)
Indiana (107)
Iowa (4)
Japan (86)
Kansas (38)
Kentucky (2)
Louisiana (2)
Maine (12)
Maryland (264)
Massachusetts (1825)
Michigan (54)
Minnesota (74)
Mississippi (1)
Missouri (19)
Montana (4)
Nebraska (8)
Nevada (22)
New Hampshire (36)
New Jersey (728)
New Mexico (12)
New York (749)
North Carolina (242)
Northern California (1158)
Ohio (53)
Oklahoma (6)
Oregon (11)
Pennsylvania (466)
Puerto Rico (7)
Rhode Island (8)
South America (241)
South Carolina (2)
Southern California (899)
Tennessee (18)
Texas (450)
United States (8666)
Utah (81)
Virginia (38)
Washington D.C. (21)
Washington State (196)
West Virginia (1)
Wisconsin (35)
177,488 Results for "earli".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Arcturus Prunes Early-Stage Pipeline, Leans Into mRNA Therapies
Arcturus is extending its cash runway into 2028 by discontinuing its early-stage vaccine candidates.
May 14, 2025
·
2 min read
·
Tristan Manalac
Opinion
Evolving Market Pressures Force Biopharma Companies to Cut Assets Early
From a higher bar for regulatory clearance to pricing limitations, drug development is more expensive than ever. This has led firms to make tough pipeline decisions early in the development process. The result may be costly for all of us.
May 21, 2025
·
5 min read
·
Michael N. Abrams
Press Releases
BioMark Diagnostics Announces Landmark Publication Validating High Specificity and Accuracy of Its Early-Stage Lung Cancer Test
Study Published in a special issue of International Journal of Molecular Sciences Confirms Test’s Ability to Distinguish Early Lung Cancer from Other Non-Cancerous Lung Diseases
May 12, 2025
·
4 min read
Infectious disease
Gilead, GSK-ViiV Move Ahead With Long-Acting HIV Options Following Early-Stage Readouts
Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and ViiV will push forward with their long-acting antivirals after touting positive early-stage results.
March 12, 2025
·
2 min read
·
Tristan Manalac
Immunology and inflammation
Kymera Soars on Early Protein Degrader Data
The candidate is being positioned as a potential oral competitor to Sanofi and Regeneron’s blockbuster Dupixent in allergy and inflammation indications.
June 3, 2025
·
1 min read
·
David Adam
Job Trends
Early-Career Professionals Face Steep Climb in Tight Market
Some companies’ preferences for people who already have industry experience and the tough job market are among the hurdles those just starting out in biopharma must navigate, two recruitment experts told
BioSpace
.
June 11, 2025
·
5 min read
·
Angela Gabriel
Press Releases
Roche to advance prasinezumab into Phase III development for early-stage Parkinson’s disease
June 16, 2025
·
6 min read
Press Releases
Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen
June 4, 2025
·
6 min read
Press Releases
Genentech to Advance Prasinezumab Into Phase III Development for Early-Stage Parkinson’s Disease
June 16, 2025
·
5 min read
Cancer
Bicara Responds to Rival Merus With Early Survival Data at ASCO25
Following Merus’ splash last month with a “best-in-disease profile” for its head and neck cancer bispecific, Bicara touted positive results for its monocolonal antibody, but analysts say Merus still has the upper hand.
June 2, 2025
·
2 min read
·
David Adam
1 of 17,749
Next
